期刊文献+

贲门癌患者外周血微转移的检测及其临床意义 被引量:1

Detection of micrometastasis in peripheral blood of patients with cardiai carcinoma and its clinical implication
原文传递
导出
摘要 目的探讨Cytokeratin 20(CK20)mRNA是否可以作为贲门癌患者外周血微转移的标志物。方法以巢式逆转录聚合酶链反应(RT-PCR)技术检测58例贲门癌患者术前、术中、术后外周血CK20mRNA的表达情况。结果58例贲门癌患者术前外周血中CK20mRNA阳性率为36.2%。接受切除术的52例患者术前、术中、术后的阳性率分别为30.8%、42.3%、13.5%。术前组与术中组阳性率的差异无统计学意义(P〉0.05),术前组与术后组阳性率的差异有统计学意义(P〈0.05),术中组与术后组阳性率的差异有统计学意义(P〈0.01)。结论CK20mRNA作为贲门癌患者外周血微转移的标志物,具有较高的敏感性和特异性。 Objective To estimate the diagnostic value of CK20mRNA as a mark to detect micrometastasis in peripheral blood of patients with cardial carcinoma. Methods CK20mRNA in peripheral blood of 58 patients with cardial carcinoma was dctected before,during and after resection by using nested RT-PCR technique. Results The positive rate of CK20mRNA in peripheral blood of the 58 patients was 36.2 %. 52 patients had undergone resection, the positive rates of CK20mRNA before,during and after resection were 30.8 % ,42.3 % and 13.5 % respectively. The positive rate of CK20mRNA in peripheral blood of the before resection group was as high as the rate of the during resection group (P 〉 0.05), the positive rate of the before resection group was lower than the after resection group( P〈0.05), the positive rates we.re significantly different between the during resection group and the after resection group(P〈 0.01). Conclusion As a mark,CK20mRNA has a high sensibitity and specificity to detect micrometastasis in peripheral blood of patients with cardial carcinoma by nested RT-PCR.
出处 《中国基层医药》 CAS 2007年第1期65-67,I0002,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 食管肿瘤 肿瘤转移 聚合酶链反应 CYTOKERATIN 20 mRNA Esophageal neoplasms Neoplasm metastasis Polymerase chain reaction Cytokeratin 20 mRNA
  • 相关文献

参考文献6

  • 1Ikeguchi M, Ohro S, Maeda Y, et al. Detection of cancer cells in the peripheral blood of gastric cancer patients. Int J Mol Med, 2003,11(2) :217-221.
  • 2Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood:the concept of early systemic disease, Int J Cancer 1996,68(6) :739-743.
  • 3Chausovsky G, Luchansky M,Figer A, et al. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas,colon, stomach, and lung. Cancer, 1999,86 ( 11 ) :2398-2405.
  • 4Funaki NO, Tanaka J, Itami A, et al, Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20mRNA. Life Sci,1997,60(9) :643-652.
  • 5Gala JL, Loric S. Sensitivity of specificity of reverse transcrip-tasepolymerase chain reaction assays:the real challenge of molecular staging of prostatic carcinomas. Int J Cancer, 1998,77(1) : 161
  • 6Chambers AF, MacDonald IC, Schmldt EE, et al. Clinical targets for anti-metastasis therapy. Adv Cancer Res, 2000,79 : 91-121.

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部